Catherine Mazzacco

Insider Reports History

Location
Pittsburgh, PA
Signature
/s/ Jeremy Hayden, Attorney-in-Fact for Catherine Mazzacco
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Catherine Mazzacco:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sight Sciences, Inc. Director Common Stock 41,015 $144,372 $3.52 11 Sep 2025 Direct
Krystal Biotech, Inc. Director Stock Option (Right to Buy) 5,000 30 Jun 2025 Direct

Insider Reports Filed by Catherine Mazzacco

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SGHT Sight Sciences, Inc. 11 Sep 2025 1 $0 4 Director 15 Sep 2025, 17:28
KRYS Krystal Biotech, Inc. 30 Jun 2025 1 $0 4 Director 30 Jun 2025, 17:59
SGHT Sight Sciences, Inc. 05 Jun 2025 1 $0 4 Director 10 Jun 2025, 21:32
KRYS Krystal Biotech, Inc. 30 Jun 2024 1 $0 4 Director 01 Jul 2024, 19:29
SGHT Sight Sciences, Inc. 06 Jun 2024 1 $0 4 Director 10 Jun 2024, 19:35
KRYS Krystal Biotech, Inc. 30 Jun 2023 1 $0 4 Director 03 Jul 2023, 16:35
SGHT Sight Sciences, Inc. 08 Jun 2023 1 $0 4 Director 03 Jul 2023, 18:04
SGHT Sight Sciences, Inc. 08 Jun 2023 0 $0 3 Director 03 Jul 2023, 17:52
KRYS Krystal Biotech, Inc. 31 Mar 2023 1 $0 4 Director 04 Apr 2023, 17:05
KRYS Krystal Biotech, Inc. 06 Mar 2023 0 $0 3 Director 09 Mar 2023, 17:26